Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer.
Pedraz-Valdunciel C, Giannoukakos S, Giménez-Capitán A, Fortunato D, Filipska M, Bertran-Alamillo J, Bracht JWP, Drozdowskyj A, Valarezo J, Zarovni N, Fernández-Hilario A, Hackenberg M, Aguilar-Hernández A, Molina-Vila MÁ, Rosell R. Pedraz-Valdunciel C, et al. Among authors: filipska m. Pharmaceutics. 2022 Sep 24;14(10):2034. doi: 10.3390/pharmaceutics14102034. Pharmaceutics. 2022. PMID: 36297470 Free PMC article.
Digital multiplexed analysis of circular RNAs in FFPE and fresh non-small cell lung cancer specimens.
Pedraz-Valdunciel C, Giannoukakos S, Potie N, Giménez-Capitán A, Huang CY, Hackenberg M, Fernandez-Hilario A, Bracht J, Filipska M, Aldeguer E, Rodríguez S, Bivona TG, Warren S, Aguado C, Ito M, Aguilar-Hernández A, Molina-Vila MA, Rosell R. Pedraz-Valdunciel C, et al. Among authors: filipska m. Mol Oncol. 2022 Jun;16(12):2367-2383. doi: 10.1002/1878-0261.13182. Epub 2022 Feb 10. Mol Oncol. 2022. PMID: 35060299 Free PMC article.
Characterising acquired resistance to erlotinib in non-small cell lung cancer patients.
Karachaliou N, Codony-Servat J, Bracht JWP, Ito M, Filipska M, Pedraz C, Chaib I, Bertran-Alamillo J, Cardona AF, Molina MA, Rosell R. Karachaliou N, et al. Among authors: filipska m. Expert Rev Respir Med. 2019 Oct;13(10):1019-1028. doi: 10.1080/17476348.2019.1656068. Epub 2019 Aug 19. Expert Rev Respir Med. 2019. PMID: 31411906 Review.
Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma.
Chaib I, Cai X, Llige D, Santarpia M, Jantus-Lewintre E, Filipska M, Pedraz C, Cui J, Yang J, Miao J, Sun R, Bracht JWP, Ito M, Codony-Servat J, Karachaliou N, Aguilar A, Rosell R, Cao P. Chaib I, et al. Among authors: filipska m. Ann Transl Med. 2019 Nov;7(22):651. doi: 10.21037/atm.2019.10.80. Ann Transl Med. 2019. PMID: 31930052 Free PMC article.
14 results